Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Ouster reported quarterly losses of 48 cents per share which beat the analyst consensus estimate of 59 cents per share. The ...
GlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTD
people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company’s ...
Yahoo Finance14d
GlucoTrack, Inc. (GCTK)
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) ...
Finanznachrichten18d
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the ...
BioSpace23d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) ...
Stockhouse23d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
Mena FN24d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP As New Medical Advisory Board Member
About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently ...
Yahoo Finance24d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...